{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T05:23:54Z","timestamp":1741411434004,"version":"3.38.0"},"reference-count":46,"publisher":"American Veterinary Medical Association (AVMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>OBJECTIVE<\/jats:bold> To determine brain region affinity for and retention of gadolinium in dogs after administration of gadodiamide and whether formalin fixation affects quantification.<\/jats:p>\n<jats:p><jats:bold>ANIMALS<\/jats:bold> 14 healthy dogs.<\/jats:p>\n<jats:p><jats:bold>PROCEDURES<\/jats:bold> 13 dogs received gadodiamide (range, 0.006 to 0.1 mmol\/kg, IV); 1 control dog received a placebo. Dogs received gadodiamide 3 to 7 days (n = 8) or 9 hours (5) before euthanasia and sample collection. Brain regions were analyzed with inductively coupled mass spectrometry (ICP-MS) and transmission electron microscopy. Associations between dose, time to euthanasia, and gadolinium retention quantities (before and after fixation in 5 dogs) were evaluated.<\/jats:p>\n<jats:p><jats:bold>RESULTS<\/jats:bold> Gadolinium retention was seen in all brain regions at all doses, except for the control dog. Exposure 3 to 7 days before euthanasia resulted in 1.7 to 162.5 ng of gadolinium\/g of brain tissue (dose-dependent effect), with cerebellum, parietal lobe, and brainstem affinity. Exposure 9 hours before euthanasia resulted in 67.3 to 1,216.4 ng of gadolinium\/g of brain tissue without dose dependency. Transmission electron microscopy revealed gadolinium in examined tissues. Fixation did not affect quantification in samples immersed for up to 69 days.<\/jats:p>\n<jats:p><jats:bold>CONCLUSIONS AND CLINICAL RELEVANCE<\/jats:bold> Gadodiamide exposure resulted in gadolinium retention in the brain of healthy dogs. Cerebellum, parietal lobe, and brainstem affinity was detected with dose dependency only in dogs exposed 3 to 7 days before euthanasia. Fixation had no effect on quantification when tissues were immersed for up to 69 days. Physiologic mechanisms for gadolinium retention remained unclear. The importance of gadolinium retention requires further investigation.<\/jats:p>","DOI":"10.2460\/ajvr.79.9.949","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T21:14:32Z","timestamp":1535490872000},"page":"949-960","source":"Crossref","is-referenced-by-count":5,"title":["Retention of gadolinium in the brains of healthy dogs after a single intravenous administration of gadodiamide"],"prefix":"10.2460","volume":"79","author":[{"given":"Jennifer M.","family":"Gambino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy R.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Buchweitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jim","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Wills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Vet Radiol Ultrasound","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1740-8261.2000.tb00419.x","article-title":"Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: a review","volume":"41","author":"Kuriashkin","year":"2000"},{"key":"ref2","series-title":"Methods in biomedical magnetic resonance imaging and spectroscopy.","first-page":"693","article-title":"Contrast agents in whole body magnetic resonance: an overview","author":"Brady","year":"2000"},{"key":"ref3","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015"},{"key":"ref4","series-title":"Vet Radiol Ultrasound","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1111\/j.1740-8261.2010.01781.x","article-title":"Optimal magnetic resonance imaging of the brain","volume":"52","author":"Robertson","year":"2011"},{"key":"ref5","series-title":"MRI contrast enhancement in the central nervous system: a case study approach.","first-page":"11","article-title":"Gd-DTPA tolerance and clinical safety","author":"Niendorf","year":"1993"},{"key":"ref6","series-title":"Chem Rev","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications","volume":"99","author":"Caravan","year":"1999"},{"key":"ref7","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3174\/ajnr.A4615","article-title":"Gadolinium-based contrast agent accumulation and toxicity: an update","volume":"37","author":"Ramalho","year":"2016"},{"key":"ref8","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017"},{"key":"ref9","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/RLI.0000000000000181","article-title":"T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats: difference between linear and macrocyclic agents","volume":"50","author":"Robert","year":"2015"},{"key":"ref10","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch","year":"2015"},{"key":"ref11","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1148\/radiol.2015150872","article-title":"High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents","volume":"276","author":"Ramalho","year":"2015"},{"key":"ref12","series-title":"AJNR Am J Neuroradiol","first-page":"1455","article-title":"Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats","volume":"19","author":"Ray","year":"1998"},{"key":"ref13","series-title":"AJNR Am J Neuroradiol","first-page":"885","article-title":"Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings","volume":"12","author":"Roman-Goldstein","year":"1991"},{"key":"ref14","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1148\/radiol.2015150805","article-title":"Residual or retained gadolinium: practical implications for radiologists and our patients","volume":"275","author":"Kanal","year":"2015"},{"key":"ref15","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014"},{"key":"ref16","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","author":"Errante","year":"2014"},{"key":"ref17","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/RLI.0000000000000154","article-title":"Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy","volume":"50","author":"Quattrocchi","year":"2015"},{"key":"ref18","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1148\/radiol.14140364","article-title":"High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration","volume":"275","author":"Kanda","year":"2015"},{"key":"ref19","series-title":"Brain Dev","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.braindev.2015.08.009","article-title":"Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast","volume":"38","author":"Roberts","year":"2016"},{"key":"ref20","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"e1637","DOI":"10.1542\/peds.2015-2222","article-title":"MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations","volume":"136","author":"Miller","year":"2015"},{"key":"ref21","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"276","author":"Kanda","year":"2015"},{"key":"ref22","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3174\/ajnr.A4378","article-title":"Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat gadolinium administration","volume":"36","author":"Adin","year":"2015"},{"key":"ref23","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","article-title":"Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function","volume":"51","author":"Murata","year":"2016"},{"key":"ref24","series-title":"J Am Coll Radiol","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jacr.2015.11.009","article-title":"National Institutes of Health perspective on reports of gadolinium deposition in the brain","volume":"13","author":"Malayeri","year":"2016"},{"key":"ref25","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1148\/radiol.10100508","article-title":"Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation","volume":"258","author":"Kasahara","year":"2011"},{"year":"2015","series-title":"FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI). Safety announcement","key":"ref26"},{"year":"2017","series-title":"EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans","key":"ref27"},{"year":"2017","series-title":"FDA drug safety communication: FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs; review to continue","key":"ref28"},{"key":"ref29","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/neuonc\/noq046","article-title":"Canine spontaneous glioma: a translational model system for convection-enhanced delivery","volume":"12","author":"Dickinson","year":"2010"},{"key":"ref30","series-title":"Epilepsia","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/epi.12138","article-title":"Canine epilepsy as a translational model?","volume":"54","author":"Potschka","year":"2013"},{"key":"ref31","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.rli.0000186569.32408.95","article-title":"Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy","volume":"41","author":"White","year":"2006"},{"key":"ref32","series-title":"Metallomics","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1039\/b905145g","article-title":"Incorporation of excess gadolinium into human bone from medical contrast agents","volume":"1","author":"Darrah","year":"2009"},{"key":"ref33","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1148\/radiol.2016162241","article-title":"No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents","volume":"282","author":"Radbruch","year":"2017"},{"year":"2010","series-title":"Oslo: GE Healthcare","key":"ref34"},{"key":"ref35","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jmri.21969","article-title":"Biodistribution of gadolinium-based contrast agents, including gadolinium deposition","volume":"30","author":"Aime","year":"2009"},{"key":"ref36","series-title":"Physiol Chem Phys Med NMR","first-page":"167","article-title":"Pharmacokinetics of GdDTPA\/dimeglumine after intravenous injection into healthy volunteers","volume":"16","author":"Weinmann","year":"1984"},{"key":"ref37","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/jmri.1880030128","article-title":"Biodistribution and toxicity of MR imaging contrast media","volume":"3","author":"Oksendal","year":"1993"},{"key":"ref38","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/RLI.0000000000000308","article-title":"Intraindividual analysis of signal intensity changes in the dentate nucleus after consecutive serial applications of linear and macrocyclic gadolinium-based contrast agents","volume":"51","author":"Radbruch","year":"2016"},{"key":"ref39","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/JCI67677","article-title":"Brain-wide pathway for waste clearance captured by contrast-enhanced MRI","volume":"123","author":"Iliff","year":"2013"},{"key":"ref40","series-title":"Sci Transl Med","first-page":"147ra111","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta","volume":"4","author":"Iliff","year":"2012"},{"key":"ref41","series-title":"Rejuvenation Res","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/rej.2013.1530","article-title":"Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases","volume":"16","author":"Mendelsohn","year":"2013"},{"key":"ref42","series-title":"Anal Chim Acta","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2012.12.007","article-title":"Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review","volume":"764","author":"Telgmann","year":"2013"},{"key":"ref43","series-title":"J Chromatogr B Biomed Sci Appl","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0378-4347(98)00190-X","article-title":"High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent gadobenate ion in plasma, urine, faeces, bile and tissues","volume":"713","author":"Arbughi","year":"1998"},{"key":"ref44","series-title":"Eur Radiol","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s00330-010-1716-8","article-title":"The fate of Gd and chelate following intravenous injection of gadodiamide in rats","volume":"20","author":"Kindberg","year":"2010"},{"key":"ref45","series-title":"Eur J Drug Metab Pharmacokinet","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF03190250","article-title":"In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging","volume":"20","author":"Normann","year":"1995"},{"key":"ref46","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/mt.2016.173","article-title":"Man's best friend: utilizing naturally occurring tumors in dogs to improve chimeric antigen receptor T-cell therapy for human cancers","volume":"24","author":"Mata","year":"2016"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/79\/9\/ajvr.79.9.949.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/79\/9\/ajvr.79.9.949.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/79\/9\/ajvr.79.9.949.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:43:50Z","timestamp":1741351430000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/79\/9\/ajvr.79.9.949.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":46,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.79.9.949","relation":{},"ISSN":["0002-9645"],"issn-type":[{"type":"print","value":"0002-9645"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}